Activation of miR-29a in activated hepatic stellate cells modulates its profibrogenic phenotype through inhibition of histone deacetylases 4

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Huang, Ying Hsien ^a   Tiao, Mao Meng ^a   Huang, Li Tung ^a   Chuang, Jiin Haur ^a   Kuo, Kuang Che ^a   Yang, Ya Ling ^a   Wang, Feng Sheng ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; GLIAL FIBRILLARY ACIDIC PROTEIN; HISTONE DEACETYLASE 4; MICRORNA 29A; HDAC5 PROTEIN, MOUSE; HISTONE; HISTONE DEACETYLASE; MICRORNA; MIRN29 MICRORNA, MOUSE; TAUROLITHOCHOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STELLATE CELL; ACETYLATION; ANIMAL; CELL CULTURE; CELL MOTION; CHOLESTASIS; COMPLICATION; DISEASE MODEL; DOWN REGULATION; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HEPATIC STELLATE CELL; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE; WOUND HEALING;

ACETYLATION; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHOLESTASIS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HEPATIC STELLATE CELLS; HISTONE DEACETYLASES; HISTONES; LIVER CIRRHOSIS; MALE; MICE, TRANSGENIC; MICRORNAS; PHENOTYPE; TAUROLITHOCHOLIC ACID; WOUND HEALING;

EID: 84942859161     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136453     Document Type: Article

References (40)

1. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134(6):1655-69. Epub 2008/05/13. doi: S0016-5085 (08) 00429-0 [pii] doi: 10.1053/j.gastro.2008.03.003 PMID: 18471545; PubMed Central PMCID: PMC2888539.
2. Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 2010;7(8):425-36. Epub 2010/06/30. doi: nrgastro.2010.97 [pii] doi: 10.1038/nrgastro.2010.97 PMID: 20585339.
3. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209-18. Epub 2005/02/04. doi: 10. 1172/JCI24282 PMID: 15690074; PubMed Central PMCID: PMC546435.
4. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455(7209):58-63. doi: 10.1038/nature07228 PMID: 18668040.
5. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2011;53(1):209-18. Epub 2010/10/05. doi: 10.1002/hep. 23922 PMID: 20890893.
6. Bandyopadhyay S, Friedman RC, Marquez RT, Keck K, Kong B, Icardi MS, et al. Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. J Infect Dis. 2011;203(12):1753-62. Epub 2011/05/25. doi: jir186 [pii] doi: 10.1093/infdis/jir186 PMID: 21606534; PubMed Central PMCID: PMC3143452.
7. Kogure T, Costinean S, Yan I, Braconi C, Croce C, Patel T. Hepatic miR-29ab1 expression modulates chronic hepatic injury. J Cell Mol Med. 2012;16(11):2647-54. Epub 2012/04/04. doi: 10.1111/j.1582-4934.2012.01578.x PMID: 22469499.
8. Khan S, Jena G, Tikoo K. Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat. Exp Mol Pathol. 2015;98(2):230-9. doi: 10. 1016/j.yexmp. 2015.01.003 PMID: 25576297.
9. Guo W, Shan B, Klingsberg RC, Qin X, Lasky JA. Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. American journal of physiology Lung cellular and molecular physiology. 2009;297(5):L864-70. doi: 10.1152/ajplung.00128.2009 PMID: 19700647; PubMed Central PMCID: PMC2777501.
10. Mannaerts I, Eysackers N, Onyema OO, Van Beneden K, Valente S, Mai A, et al. Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29. PLoS One. 2013;8(1):e55786. doi: 10.1371/journal.pone.0055786 PMID: 23383282; PubMed Central PMCID: PMC3561334.
11. Van Beneden K, Mannaerts I, Pauwels M, Van Den Branden C, Van Grunsven LA. HDAC inhibitors in experimental liver and kidney fibrosis. Fibrogenesis & tissue repair. 2013;6(1):1. doi: 10.1186/1755-1536-6-1 PMID: 23281659; PubMed Central PMCID: PMC3564760.
12. Lin CL, Lee PH, Hsu YC, Lei CC, Ko JY, Chuang PC, et al. MicroRNA-29a promotion of nephrin acety-lation ameliorates hyperglycemia-induced podocyte dysfunction. J Am Soc Nephrol. 2014;25(8):1698-709. doi: 10.1681/ASN.2013050527 PMID: 24578127; PubMed Central PMCID: PMC4116051.
13. Wang FS, Chung PC, Lin CL, Chen MW, Ke HJ, Chang YH, et al. MicroRNA-29a Protects Against Glu-cocorticoid-Induced Bone Loss and Fragility in Rats by Orchestrating Bone Acquisition and Resorption. Arthritis Rheum. 2013;65(6):1530-40. doi: 10.1002/art.37948 PMID: 23529662.
14. Tiao MM, Wang FS, Huang LT, Chuang JH, Kuo HC, Yang YL, et al. MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway. Apoptosis. 2014;19(1):30-41. doi: 10.1007/s 10495-013-0909-4 PMID: 24052410.
15. Hsiao YC, Chang HH, Tsai CY, Jong YJ, Horng LS, Lin SF, et al. Coat color-tagged green mouse with EGFP expressed from the RNA polymerase II promoter. Genesis. 2004;39(2):122-9. doi: 10.1002/gene.20038 PMID: 15170698.
16. Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA. 1985;82(24):8681-5. Epub 1985/12/01. PMID: 3909149; PubMed Central PMCID: PMC391500.
17. Chou MH, Huang YH, Lin TM, Du YY, Tsai PC, Hsieh CS, et al. Selective activation of Toll-like receptor 7 in activated hepatic stellate cells may modulate their profibrogenic phenotype. The Biochemical journal. 2012;447(1):25-34. doi: 10.1042/BJ20112058 PMID: 22765640.
18. Kwiecinski M, Noetel A, Elfimova N, Trebicka J, Schievenbusch S, Strack I, et al. Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction. PLoS One. 2011;6(9):e24568. Epub 2011/09/21. doi: 10.1371/journal.pone.0024568 PONE-D-11-04075 [pii]. PMID: 21931759; PubMed Central PMCID: PMC3170366.
19. Ko JY, Chuang PC, Chen MW, Ke HC, Wu SL, Chang YH, et al. MicroRNA-29a ameliorates glucocorti-coid-induced suppression of osteoblast differentiation by regulating beta-catenin acetylation. Bone. 2013;57(2):468-75. doi: 10.1016/j.bone.2013.09.019 PMID: 24096265.
20. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285(5425):248-51. Epub 1999/07/10. doi: 7585 [pii]. PMID: 10398600.
21. Hillebrandt S, Wasmuth HE, Weiskirchen R, Hellerbrand C, Keppeler H, Werth A, et al. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nature genetics. 2005;37(8):835-43. doi: 10.1038/ng1599 PMID: 15995705.
22. Tennakoon AH, Izawa T, Wijesundera KK, Murakami H, Katou-Ichikawa C, Tanaka M, et al. Immuno-histochemical characterization of glial fibrillary acidic protein (GFAP)-expressing cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA). Experimental and toxicologic pathology: official journal of the GesellschaftfurToxikologische Pathologie. 2015;67(1):53-63. doi: 10. 1016/j.etp. 2014.09.008 PMID: 25446803.
23. Carotti S, Morini S, Corradini SG, Burza MA, Molinaro A, Carpino G, et al. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C. LiverTranspl. 2008;14(6):806-14. doi: 10.1002/lt.21436 PMID: 18508359.
24. Niki T, De Bleser PJ, Xu G, Van Den Berg K, Wisse E, Geerts A. Comparison of glial fibrillary acidic protein and desmin staining in normal and CCl4-inducedfibrotic rat livers. Hepatology. 1996;23(6):1538-45. doi: 10.1002/hep. 510230634 PMID: 8675175.
25. Salguero Palacios R, Roderfeld M, Hemmann S, Rath T, Atanasova S, Tschuschner A, et al. Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice. Lab Invest. 2008;88(11):1192-203. doi: 10.1038/labinvest.2008.91 PMID: 18794850.
26. Qin W, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM, et al. TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J AmSoc Nephrol. 2011;22(8):1462-74. Epub 2011/07/26. doi: ASN.2010121308 [pii] doi: 10.1681/ASN.2010121308 PMID: 21784902; PubMed Central PMCID: PMC3148701.
27. Winbanks CE, Wang B, Beyer C, Koh P, White L, Kantharidis P, et al. TGF-beta regulates miR-206and miR-29 to control myogenic differentiation through regulation of HDAC4. J Biol Chem. 2011;286(16):13805-14. doi: 10.1074/jbc. M110.192625 PMID: 21324893; PubMed Central PMCID: PMC3077581.
28. Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology. 2014;147(3):577-94e1. doi: 10.1053/j.gastro.2014.06.043 PMID: 25066692.
29. Harada K, Chiba M, Okamura A, Hsu M, Sato Y, Igarashi S, et al. Monocyte chemoattractantprotein-1 derived from biliary innate immunity contributes to hepatic fibrogenesis. Journal of clinical pathology. 2011;64(8):660-5. doi: 10.1136/jclinpath-2011-200040 PMID: 21527401.
30. Wang Z, Qin G, Zhao TC. HDAC4: mechanism of regulation and biological functions. Epigenomics. 2014;6(1):139-50. doi: 10.2217/epi.13.73 PMID: 24579951.
31. Liu Y, Wang Z, Wang J, Lam W, Kwong S, Li F, et al. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-beta and vascular endothelial growth factor signalling. Liver international: official journal of the International Association for the Study of the Liver. 2013;33(4):504-15. doi: 10.1111/liv. 12034 PMID: 23279742.
32. Niki T, Rombouts K, De Bleser P, De Smet K, Rogiers V, Schuppan D, et al. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Hepatology. 1999;29(3):858-67. doi: 10.1002/hep. 510290328 PMID: 10051490.
33. Mannaerts I, Nuytten NR, Rogiers V, Vanderkerken K, Van Grunsven LA, Geerts A. Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo. Hepatology. 2010;51(2):603-14. doi: 10.1002/hep. 23334 PMID: 19957378.
34. Ko JY, Chuang PC, Chen MW, Ke HC, Wu SL, Chang YH, et al. MicroRNA-29a ameliorates glucocorti-coid-induced suppression of osteoblast differentiation by regulating beta-catenin acetylation. Bone. 2013;57(2):468-75. doi: 10.1016/j.bone.2013.09.019 PMID: 24096265.
35. Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J RespirCell Mol Biol. 2011;45(2):287-94. Epub 2010/10/26. doi: 2010-0323OC [pii] doi: 10.1165/rcmb.2010-0323OC PMID: 20971881; PubMed Central PMCID: PMC3175558.
36. Port JD, Walker LA, Polk J, Nunley K, Buttrick PM, Sucharov CC. Temporal expression of miRNAs and mRNAs in a mouse model of myocardial infarction. Physiol Genomics. 2011;43(19):1087-95. doi: 10. 1152/physiolgenomics.00074.2011 PMID: 21771878; PubMed Central PMCID: PMC3217325.
37. Boon RA, Seeger T, Heydt S, Fischer A, Hergenreider E, Horrevoets AJ, et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res. 2011;109(10):1115-9. doi: 10.1161/CIRCRESAHA.111.255737 PMID: 21903938.
38. Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores GJ. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest. 2003;83(5):655-63. PMID: 12746475.
39. Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, et al. Kupffercell engulf-ment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology. 2003;38(5):1188-98. doi: 10.1053/jhep. 2003.50472 PMID: 14578857.
40. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-betain hepatic fibrosis. Front Biosci. 2002;7:d793-807. PMID: 11897555.